Perfluoroalkyl acids: Recent research highlights

Reproductive Toxicology

Volumn 33, Issue 4, 2012, Pages 405-409

  Lau, Christopher ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Perfluoroalkyl acids

Indexed keywords

ESTROGEN; ORGANOFLUORINE DERIVATIVE; PERFLEXANE; PERFLUORO COMPOUND; PERFLUOROALKYL ACID; PERFLUOROALKYL SULFONATE; PERFLUOROBUTYRIC ACID; PERFLUORONONANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROGESTERONE; UNCLASSIFIED DRUG;

APOPTOSIS; BIOLOGICAL MONITORING; CANCER RISK; DNA DAMAGE; EDITORIAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FETUS RISK; HEALTH HAZARD; HUMAN; KIDNEY TUBULE ABSORPTION; LACTATION; NEWBORN MORTALITY; NONHUMAN; POLLUTION TRANSPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; TRANSCRIPTION REGULATION;

ALKANESULFONIC ACIDS; ANIMALS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; HUMANS; OCTANOIC ACIDS; RESEARCH DESIGN;

EID: 84861532313     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.03.002     Document Type: Editorial

References (34)

1. USEPA. Inert ingredient; revocation of the tolerance exemption for mono- and bis-(IA, 1H, 2H, 2H-perfluoroalkyl) phosphates where the alkyl group is even numbered and in the C6-C12 range. U.S. EPA Public Docket OPP 2006-0253. 40 CFR 180. Washington, DC; 2006. http://regulations.justia.com/regulations/fedreg/2006/08/09/E6-12541.html.
2. D'eon J.C., Mabury S.A. Uptake and eliminated of perfluorinated phosphonic acids in the rat. Environ Toxicol Chem 2010, 29:1319-1329.
3. D'eon J.C., Crozier P.W., Furdui C.I., Reiner E.J., Libelo E.L., Mabury S.A. Perfluorinated phosphonic acids in Canadian surface waters and wastewater treatment plant effluent: discovery of a new class of perfluorinated acids. Environ Toxicol Chem 2009, 28:2101-2107.
4. Chang S., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J., Froehlich J.W., et al. Negative bias from analog methods used in the analysis of free thyroid hormones in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 2007, 234:21-33.
5. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 2011, 45:8037-8045.
6. Kato K., Calafat A.M., Wong L.Y., Wanigatunga A.A., Caudill S.P., Needham L.L. Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol 2009, 43:2641-2647.
7. Calafat A.M., Kuklenyik Z., Caudill S.P., Reidy J.A., Needham L.L. Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol 2006, 40:2128-2134.
8. Schecter A., Malik-Bass N., Calafat A.M., Kato K., Colacino J.A., Gent T.L., et al. Polyfluoroalkyl compounds in Texas children from birth through 12 years of age. Environ Health Perspect 2012, 10.1289/ehp.1104325.
9. Brede E., Wilhelm M., Göen T., Müller J., Rauchfuss K., Kraft M., et al. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 2010, 213:217-223.
10. Bartell S.M., Calafat A.M., Lyu C., Kato K., Ryan P.B., Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 2010, 118:222-228.
11. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998, 40:614-622.
12. Olsen G.W., Burris J.M., Mandel J.H., Zobel L.R. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med 1999, 41:799-806.
13. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 2003, 45:260-270.
14. US Environmental Protection Agency. Provisional health advisory for PFOA and PFOS in drinking water; 2009. http://water.epa.gov/action/advisories/drinking/upload/2009_01_15_criteria_drinking_pha-PFOA_PFOS.pdf.
15. Minnesota health-based drinking water guidance for perfluorinated chemicals; 2009. http://www.health.state.mn.us/divs/eh/risk/guidance/gw/table.html.
16. New Jersey health-based drinking water guidance for PFOA; 2009. http://www.state.nj.us/dep/watersupply/pfoa.htm.
17. Drinking Water Commission, German Ministry of Health. Provisional evaluation of PFT in drinking water with the guide substances perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) as examples; 2006. http://www.umweltbundesamt.de/uba-info-presse-e/hintergrund/pft-in-drinking-water.pdf.
18. European Food Safety and Authority Opinion of the scientific panel on contaminants in the food chain on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. EFSA J 2008, 653:1-131. (available from: http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902012410.htm).
19. Committee on Toxicity of Chemicals in Food, Consumer Products and The Environment. COT statement on the tolerable daily intake for perfluorooctanoic acid; 2006. http://www.food.gov.uk/multimedia/pdfs/cotstatementpfoa200610.pdf.
20. Committee on Toxicity of Chemicals in Food, Consumer Products and The Environment. COT statement on the tolerable daily intake for perfluorooctane sulfonate; 2006. http://www.food.gov.uk/multimedia/pdfs/cotstatementpfos200609.pdf.
21. German Federal Institute for Risk Assessment. High levels of perfluorinated organic surfactants in fish are likely to be harmful to human health Statement No. 21/2006; 2006. http://www.bfr.bund./cd/8172.
22. Vanden Heuvel J.P., Kuslikis B.I., Van Ragelghem M.L., Peterson R.E. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J Biochem Toxicol 1991, 6:83-92.
23. Ohmori K., Kudo N., Katayama K., Kawashima Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 2003, 184:135-140.
24. Hundley S.G., Sarrif A.M., Kennedy G.L. Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem Toxicol 2006, 29:137-145.
25. Chang S.C., Das K., Ehresman D.J., Ellefson M.E., Gorman G.S., Hart J.A., et al. Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water. Toxicol Sci 2008, 104:40-53.
26. Olsen G.W., Chang S.C., Noker P.E., Gorman G.S., Ehresman D.J., Lieder P.H., et al. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology 2009, 256:65-74.
27. Chengelis C.P., Kirkpatrick J.B., Myers N.R., Shinohara M., Stetson P.L., Sved D.W. Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats. Reprod Toxicol 2009, 27:400-406.
28. Benskin J.P., De Silva A.O., Martin L.J., Arsenault G., McCrindle R., Riddell N., et al. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 1: single dose. Environ Toxicol Chem 2009, 28:542-554.
29. Tatum-Gibbs K., Wambaugh J., Das K.P., Zehr R.D., Strynar M.J., Lindstrom A.B., et al. Comparative pharmacokinetics of perfluorononanoic aicd in rat and mouse. Toxicology 2011, 281:48-55.
30. Lou I., Wambaugh J.F., Lau C., Hanson R.G., Lindstrom A.B., Strynar M.J., et al. Modeling single and repeated dose pharmacokinetics of PFOA in mice. Toxicol Sci 2009, 107:331-341.
31. Hanhijarvi H., Ylinen M., Haaranen T., Nevalainen T. A proposed species difference in the renal excretion of perfluorooctanoic acid in the beagle dog and rat. New development in biosciences: their implications for laboratory animal sciences 1988, 409-412. Martinus Nijhoff Publishers, Dordrecht, The Netherlands. A.C. Beynen, H.A. Solleveld (Eds.).
32. Butenhoff J.L., Kennedy G.L., Hinderliter P.M., Lieder P.H., Jung R., Hansen K.J., et al. Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol Sci 2004, 82:394-406.
33. Harada K., Inoue K., Morikawa A., Yoshinaga T., Saito N., Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 2005, 99:253-261.
34. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007, 115:1298-1305.